Ranking treatments in the network meta-analysis should consider the certainty of evidence

Affiliations

¹ Evidence Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, China; Health Technology Assessment Center, Evidence Based Social Science Research Center, School of Public Health, Lanzhou University, Lanzhou 730000, China; Department of Health Research Methods, Evidence and Impact, Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada.
² Department of Health Research Methods, Evidence and Impact, Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada.
³ Michael G DeGroote Institute for Pain Research and Care, McMaster University, Hamilton, ON, Canada.
⁴ Evidence Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, China; Health Technology Assessment Center, Evidence Based Social Science Research Center, School of Public Health, Lanzhou University, Lanzhou 730000, China. Electronic address: yangkh-ebm@lzu.edu.cn.

Comment

Meixuan Li et al. Lancet Gastroenterol Hepatol. 2022 Apr.

. 2022 Apr;7(4):287-288.

doi: 10.1016/S2468-1253(21)00470-2.

¹ Evidence Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, China; Health Technology Assessment Center, Evidence Based Social Science Research Center, School of Public Health, Lanzhou University, Lanzhou 730000, China; Department of Health Research Methods, Evidence and Impact, Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada.
² Department of Health Research Methods, Evidence and Impact, Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada.
³ Michael G DeGroote Institute for Pain Research and Care, McMaster University, Hamilton, ON, Canada.
⁴ Evidence Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, China; Health Technology Assessment Center, Evidence Based Social Science Research Center, School of Public Health, Lanzhou University, Lanzhou 730000, China. Electronic address: yangkh-ebm@lzu.edu.cn.

No abstract available

Conflict of interest statement

We declare no competing interests.

Ranking treatments in the network meta-analysis should consider the certainty of evidence - Authors' reply.
Lasa JS, Olivera PA, Peyrin-Biroulet L. Lasa JS, et al. Lancet Gastroenterol Hepatol. 2022 Apr;7(4):288. doi: 10.1016/S2468-1253(22)00018-8. Lancet Gastroenterol Hepatol. 2022. PMID: 35278398 No abstract available.

Efficacy and safety of biologics and small molecule drugs for patients with moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis.
Lasa JS, Olivera PA, Danese S, Peyrin-Biroulet L. Lasa JS, et al. Lancet Gastroenterol Hepatol. 2022 Feb;7(2):161-170. doi: 10.1016/S2468-1253(21)00377-0. Epub 2021 Nov 29. Lancet Gastroenterol Hepatol. 2022. PMID: 34856198